Search

Search results

49 results found

Lorem Ipsum

Lorem Ipsum, MD Co-creation targeted collaborate, triple bottom line radical segmentation.

Srivatsan Raghavan

Srivatsan Raghavan, MD/PhD Dr. Srivatsan Raghavan, MD, PhD, is a medical oncologist and physician-scientist at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital and an Instructor in Medicine at Harvard Medical School. He specializes in the clinical care of patients with...

Aswanth Mahalingam

Aswanth Mahalingam Aswanth is a Research Technician in the Raghavan Lab at Dana-Farber Cancer Institute (DFCI). His research focuses on studying the factors that govern cell states in pancreatic cancer. Aswanth completed his Master's degree in Biotechnology at the Indian Institute of Technology...

Sharon Bader

Sharon Bader Sharon is an Associate Computational Biologist in the Raghavan Lab at Dana-Farber Cancer Institute (DFCI). Her research focuses on studying cell states and their impact on gene dependencies and drug response. Sharon completed her Master of Science (MSc) degree in Biomedical Engineering...

Akshaya Thoutam

Akshaya Thoutam Akshaya is a Pre-doctoral research assistant in the BioML Group at Microsoft Research. She holds a BS in Neuroscience from Georgia Tech with a minor in Health and Medical sciences. Akshaya’s research interests lie at the intersection of computational biology, neuroscience, genomics...

Madeline Hughes

Madeline Hughes Maddy is an Applied Scientist in the BioML group at Microsoft Research. Prior to joining Microsoft, Maddy received her undergraduate degree from Brown University in Computer Science (A.B.) and Biology (A.B.).

Ava Amini

Ava Amini PhD Ava Amini is a senior researcher at Microsoft Research in Cambridge, MA. Her research focuses on engineering new technologies for precision medicine and has spanned machine learning, bioengineering, and cancer biology. Ava completed her PhD in Biophysics at Harvard University and the...

Jessica Ewald

I am interested in trying to predict and gain insights into adverse health outcomes in living organisms from rich cellular profiling data collected from in vitro experiments.